Correlation between Toll-like Receptor Gene Polymorphisms and Idiopathic Nephrotic Syndrome in Chinese Children

Abstract

Objective

Idiopathic nephrotic syndrome (INS) is the most common glomerular disease in children. Toll-like receptors (TLRs) have been reported to be associated with response to steroid treatment in children with INS. Nevertheless, the correlation between TLR genes and the progression of INS has not yet been clarified. The present study aimed to investigate the association of single-nucleotide polymorphisms (SNPs) in TLR2, TLR4, and TLR9 with susceptibility to INS as well as the clinical phenotyping of steroid responsiveness in Chinese children with INS.

Methods

A total of 183 pediatric inpatients with INS were included and given standard steroid therapy. Based on their clinical response to steroids, the patients were classified into three groups: steroid-sensitive nephrotic syndrome (SSNS), steroid-dependent nephrotic syndrome (SDNS), and steroid-resistant nephrotic syndrome (SRNS). A total of 100 healthy children were employed as controls. The blood genome DNA was extracted from each participant. Six SNPs (rs11536889, rs1927914, rs7869402, rs11536891, rs352140, and rs3804099) in TLR2, TLR4, and TLR9 were selected and detected by multiplex polymerase chain reaction with next-generation sequencing to assess TLR gene polymorphisms.

Results

Among the 183 patients with INS, 89 (48.6%) had SSNS, 73 (39.9%) had SDNS, and 21 (11.5%) had SRNS. No significant difference was found in the genotype distribution between healthy children and patients with INS. However, the genotype and allele frequencies of TLR4 rs7869402 were significantly different between SRNS and SSNS. Compared with patients with the C allele and CC genotype, patients with the T allele and CT genotype had an increased risk of SRNS.

Conclusion

TLR4 rs7869402 affected the steroid response in Chinese children with INS. It might be a predictor for the early detection of SRNS in this population.

Keywords

children / idiopathic nephrotic syndrome / polymorphisms / Toll-like receptor genes / steroid resistance

References

[1] NooneDG, IijimaK, ParekhR. Idiopathic nephrotic syndrome in children. Lancet, 2018, 392(10141): 61-74

[2] ChenJ, QiaoXH, MaoJH. Immunopathogenesis of idiopathic nephrotic syndrome in children: two sides of the coin. World J Pediatr, 2021, 17(2): 115-122

[3] IijimaK, SakoM, NozuK. Rituximab for nephrotic syndrome in children. Clin Exp Nephrol, 2017, 21(2): 193-202

[4] TullusK, WebbH, BaggaA. Management of steroid-resistant nephrotic syndrome in children and adolescents. Lancet Child Adolesc Health, 2018, 2(12): 880-890

[5] SameerAS, NissarS. Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility. Biomed Res Int, 2021, 2021: 1157023

[6] BergalloM, LoiaconoE, GambarinoS, et al.. Toll-like receptors are essential for the control of endogenous retrovirus expression in Idiopathic Nephrotic Syndrome. Minerva Urol Nefrol, 2017, 69(2): 201-208

[7] MishraOP, KumarR, NarayanG, et al.. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome. Pediatr Nephrol, 2017, 32(8): 1355-1361

[8] GbadegesinRA, AdeyemoA, WebbNJ, et al.. HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome. J Am Soc Nephrol, 2015, 26(7): 1701-1710

[9] HinkesBG, MuchaB, VlangosCN, et al.. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics, 2007, 119(4): e907-e919

[10] FeiS, GuiZ, FengD, et al.. Association Between a TLR2 Gene Polymorphism (rs3804099) and Proteinuria in Kidney Transplantation Recipients. Front Genet, 2021, 12: 798001

[11] AbdolvahabiR, SarrafnejadA, NafarM, et al.. Association Between TLR2, TLR4, and CD14 Gene Polymorphisms and Acute Rejection in Kidney Transplant. Exp Clin Transplant, 2018, 16(1): 31-37

[12] ElloumiN, FakhfakhR, AbidaO, et al.. Relevant genetic polymorphisms and kidney expression of Toll-like receptor (TLR)-5 and TLR-9 in lupus nephritis. Clin Exp Immunol, 2017, 190(3): 328-339

[13] Subspecialty Group of Renal Diseases, the Society of Pediatrics, Chinese Medical Association. Evidence-based guideline on diagnosis and treatment of steroid-sensitive, relapsing/steroid-dependent nephrotic syndrome in children(2016). Zhonghua Er Ke Za Zhi (Chinese), 2017, 55(10): 729-734

[14] LiT, JingJ, DongN, et al.. TLR4 rs1927914 polymorphism contributes to serum TLR4 levels in patients with aortic aneurysm. Exp Mol Pathol, 2021, 119: 104609

[15] WuH, GaoH, LiA, et al.. Impact of Genetic Variation in TLR4 3′UTR on NSCLC Genetic Susceptibility. J Oncol, 2020, 2020: 7593143

[16] HamannL, GlaeserC, HamprechtA, et al.. Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin Chim Acta, 2006, 364(1–2): 303-307

[17] ColucciM, CorpettiG, EmmaF, et al.. Immunology of idiopathic nephrotic syndrome. Pediatr Nephrol, 2018, 33(4): 573-584

[18] CampbellRE, ThurmanJM. The Immune System and Idiopathic Nephrotic Syndrome. Clin J Am Soc Nephrol, 2022, 17(12): 1823-1834

[19] ChenSY, ChenCH, HuangYC, et al.. Genetic susceptibility to idiopathic membranous nephropathy in high-prevalence Area, Taiwan. Biomedicine (Taipei), 2014, 4: 9

[20] ChenYT, WeiCC, NgKL, et al.. Toll-like receptor 9 SNPs are susceptible to the development and progression of membranous glomerulonephritis: 27 years follow-up in Taiwan. Ren Fail, 2013, 35(10): 1370-1375

[21] ShelkeV, KaleA, AndersHJ, et al.. Epigenetic regulation of Toll-like receptors 2 and 4 in kidney disease. J Mol Med (Berl), 2022, 100(7): 1017-1026

[22] LarkinsNG, LiuID, WillisNS, et al.. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev, 2020, 4: D2290

[23] HorinouchiT, NozuK, IijimaK. An updated view of the pathogenesis of steroid-sensitive nephrotic syndrome. Pediatr Nephrol, 2022, 37(9): 1957-1965

[24] YangM, KumarRK, FosterPS. Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN-gamma and TLR4/MyD88 pathways. J Immunol, 2009, 182(8): 5107-5115

[25] KuznetsovNV, ZargariA, GielenAW, et al.. Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients. BMC Gastroenterol, 2014, 14: 79

[26] BrownHJ, LockHR, WolfsTG, et al.. Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol, 2007, 18(6): 1732-1739

[27] CunninghamPN, WangY, GuoR, et al.. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol, 2004, 172(4): 2629-2635

[28] SatoK, YoshimuraA, KanekoT, et al.. A single nucleotide polymorphism in 3′-untranslated region contributes to the regulation of Toll-like receptor 4 translation. J Biol Chem, 2012, 287(30): 25163-25172

[29] LiZ, GaoH, LiuY, et al.. Genetic variants in the regulation region of TLR4 reduce the gastric cancer susceptibility. Gene, 2021, 767: 145181

[30] JiangS, MaJ, YeS, et al.. Associations Among Disseminated Intravascular Coagulation, Thrombocytopenia Cytokines/Chemokines and Genetic Polymorphisms of Toll-Like Receptor 2/4 in Chinese Patients with Sepsis. J Inflamm Res, 2022, 15: 1-15